Tech Company Financing Transactions
Axion BioSystems Funding Round
Private investors participated in a $8 million funding round for Axion BioSystems. The funding round closed on 10/6/2018.
Transaction Overview
Company Name
Announced On
10/6/2018
Transaction Type
Venture Equity
Amount
$8,000,380
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. 31 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1819 Peachtree Rd. Northeast 350
Atlanta, GA 30309
USA
Atlanta, GA 30309
USA
Phone
Website
Email Address
Overview
Axion Biosystems is a life science company developing technologies that solve problems related to human heart and brain activity.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chairman
Glenn Epstein
Chief Executive Officer
Thomas O'Brien
Chief Scientific Officer
Michael Clements
Chief Technical Officer
James Ross
VP - Operations
Robert Grier
VP - Sales
James Filippini
Browse more venture capital transactions:
Prev: 10/6/2018: Brex venture capital transaction
Next: 10/6/2018: Deliverr venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs